Meeting Overview

Southwest Prostate Cancer Symposium
Scottsdale, Arizona
April 11-14, 2019

Program Overview:
Co-chaired by Doctors Nelson N. Stone, MD and Richard G. Stock, MD, the Southwest Prostate Cancer Symposium™ (formerly Scottsdale Prostate Cancer Symposium) has been held in Scottsdale, AZ for 22 years. This multi-day conference is intended for urologists, radiation oncologists, medical oncologists, physicists, and other healthcare professionals involved in the treatment of prostate cancer. It will educate the attendees about advances in management of localized and advanced prostate cancer with a focus on imaging, technology, and training in the related devices.

Educational Goals:
The goal of this educational program is to equip urologists, radiation oncologists, medical oncologists, physicists, and other healthcare professionals involved in prostate cancer care with the up-to-date clinical knowledge and tools they need to best treat their patients. The program aims to provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease.

This program also offers training sessions for healthcare professionals to become proficient in imaging, scanning, and prostate cancer treatment related devices on site.

SPCS 2018 Sponsors

PLATINUM LEVEL SUPPORT
Astellas Pharma US and Pfizer Oncology

GOLD LEVEL SUPPORT
Augmenix, Inc.
Janssen Biotech

BRONZE LEVEL SUPPORT
3DBiopsy
Bayer Healthcare Pharmaceuticals

Program Directors

Nelson N. Stone, MD

Professor of Urology and Radiation Oncology
Icahn School of Medicine at Mount Sinai
CEO and President 3D Biopsy, Inc.
New York, New York

Nelson N. Stone, MD is Professor of Urology and Radiation Oncology at The Icahn School of Medicine at Mount Sinai and at the Derald H. Ruttenberg Cancer Center at Mount Sinai. He also serves as CEO of 3D Biopsy, LLC. Dr. Stone earned his medical degree from the University of Maryland in 1979. He completed a general surgical residency in 1981 at the University of Maryland, followed by residency in urology at the University of Maryland. He then completed a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center and a research fellowship in biochemical endocrinology at Rockefeller University in 1986. He was Chief of Urology at Elmhurst Hospital from 1989-1996. Dr. Stone has founded several medical companies and serves on the editorial board of many scientific journals. He is a member of many professional societies, including the Prostate Conditions Education Council, the Society for Minimally Invasive Therapy, the New York State Urological Society, the American Association of Clinical Urologists, and the American Urologic Association. Dr. Stone has participated in approximately 25 research studies on prostate cancer and has authored more than 400 articles, abstracts, and book chapters, most on prostate cancer. He invented the real-time technique for prostate seed implantation in 1990 and has trained more than 5,000 physicians worldwide on prostate brachytherapy through his company ProSeed. His current company, 3DBiopsy, Inc., is developing variable length biopsy devices, mapping software and an integrated pathology system.

Richard G. Stock, MD

Professor of Radiation Oncology
Director of Genito-Urinary Radiation Oncology
The Icahn School of Medicine at Sinai School
New York, New York

Dr. Richard Stock has dedicated his career to delivering the highest quality care to patients using the most advanced technology available, including intensity modulated radiation therapy (IMRT), Novalis shaped beam radiosurgery, real-time ultrasound guided prostate seed implants and Mammosite, all of which allows for meticulously targeting the tumor while achieving maximal sparing of normal tissues. Dr. Stock has served on the board of American College of Radiology Testing and the American Brachytherapy Society, where he is member at large, and as guest editor of a special Brachytherapy issue of Techniques in Urology. He has lectured and presented at dozens of meetings and symposiums across the country and internationally, including New York, San Francisco, Chicago, Philadelphia, Boston, Spain, Holland, France and Japan. Dr. Stock completed his internship at Beth Israel Medical Center and his specialty training at Memorial Sloan-Kettering Cancer Center. He is listed in America’s Top Doctors.